البريد الإلكتروني: bd@sidmexinovia.com
رقم الهاتف: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
الرئيسية >
Denoci OP 60mg Injection
Denoci OP 60mg Injection
Manufacturer/Marketed By : CIPLA LTD
$164.72 $98.83
Denoci OP 60mg injection consists of the active ingredient Denosumab. It is a medication used to treat osteoporosis, characterized by weakened bones. It is also prescribed to prevent bone complications...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
DENOSUMAB
Active Pharmaceutical Ingredient
Denoci OP 60mg Injection
164.72 US$
98.83 US$
Denoci OP 60mg injection consists of the active ingredient Denosumab. It is a medication used to treat osteoporosis, characterized by weakened bones. It is also prescribed to prevent bone complications in patients with certain types of cancer, such as multiple myeloma and bone metastases. Denoci OP 60mg injection works by inhibiting a protein called RANK ligand, which plays a role in the breakdown of bone tissue. Studies proved it can significantly increase bone density, reducing fracture risk in postmenopausal women with osteoporosis and patients with cancer-related bone loss. Close monitoring of renal function may be necessary for patients with moderate renal impairment. Denoci OP 60mg injection should not be used in individuals with known hypersensitivity or allergic reactions to its components. Adequate calcium and vitamin D supplementation is required to ensure during the treatment. It is not approved for use in children and adolescents. Its safety and effectiveness in pediatric populations have not been established, so its use is contraindicated in individuals under 18. This medication should be used cautiously in individuals with pre-existing hypoparathyroidism, characterized by low parathyroid hormone levels.
Active Pharmaceutical Ingredient
الاستخدامات
• Osteoporosis
• Bone loss due to hormonal therapy in breast or prostate cancer
• Multiple myeloma (cancer affects plasma cells in the bone marrow)
• Bone metastases (cancer that spreads to bone)
فوائد
Denoci OP 60mg injection has therapeutic effects that include reducing fracture risk, increasing bone mineral density, and improving overall bone health. By inhibiting bone resorption through its action on RANK ligands, this medication helps to strengthen bones and decrease the likelihood of fractures in individuals with osteoporosis or those at high risk. It also increases bone mineral density, an important marker of bone strength. These therapeutic effects contribute to improved bone health and a reduced risk of fractures, ultimately enhancing the quality of life for patients.
تأثيرات جانبية
Denoci OP 60mg injection can cause side effects like all medications, although not everyone who takes it will experience them.
الآثار الجانبية الأكثر شيوعًا
• Injection site reactions
• Back pain
• Musculoskeletal pain
• Infections
• Abdominal pain
• Headache
• Hypophosphatemia (low blood phosphate levels)
الآثار الجانبية الشائعة
• Osteonecrosis of the jaw (severe necrosis or death of jaw cells)
• Atypical femoral fractures
• Hypocalcemia (low blood calcium levels)
كيفية الاستخدام
Denoci OP 60mg injection is given as an injection by healthcare professionals. The dosage and duration of treatment will be based on the individual's condition and response to the medication and should be determined by a healthcare provider.
نصائح السلامة
• Breast Feeding: Whether Denoci OP 60mg injection is excreted in milk is unknown. So it is better to consult a healthcare provider if you are a breastfeeding mother before taking this medication.
• Alcohol: It is generally recommended to avoid or limit alcohol consumption while taking Denoci OP 60mg injection. Alcohol can interact with this medication, potentially increasing the risk of side effects.
• Liver: Denoci OP 60mg injection is primarily metabolized in the liver, and its safety has not been extensively studied in individuals with severe liver impairment. It is crucial to communicate any pre-existing liver conditions or changes in liver function to your healthcare provider to ensure this medication's safe and effective use.
• Lungs: If you have a lung or respiratory disorders history, it is important to consult your healthcare provider before taking Denoci OP 60mg injection.
• Driving: Patients receiving Denoci OP 60mg injection should be advised to avoid driving or operating machinery if they experience side effects such as fatigue, dizziness, or blurred vision, impairing a patient's ability to drive or operate machinery safely.
• Pregnancy: The safety of using Denoci OP 60mg injection during pregnancy has not been established. Limited studies are available regarding the use of this medication in pregnant women, so it is recommended to use caution and consult a doctor before considering its use during pregnancy.
تنصل
تسعى شركة Sidmex Inovia جاهدة لتوفير معلومات دقيقة وموثوقة؛ ومع ذلك، فإن جميع المحتويات الموجودة على هذا الموقع الإلكتروني، بما في ذلك أوصاف المنتجات ومكوناتها، هي لأغراض إعلامية فقط ولا ينبغي اعتبارها بديلاً عن المشورة الطبية المهنية أو التشخيص أو العلاج.
يُنصح المستخدمون باستشارة أخصائي رعاية صحية مؤهل قبل اتخاذ أي قرارات طبية. لا ينبغي استخدام المعلومات المقدمة للتشخيص الذاتي أو العلاج الذاتي.
جميع المنتجات المذكورة مخصصة حصراً لأغراض التعاملات التجارية بين الشركات والاستفسارات بالجملة. لا تشجع شركة سيدمكس إينوفيا الاستخدام المباشر من قبل المستهلكين، وتهدف إلى دعم العلاقة بين أخصائي الرعاية الصحية والمريض، لا استبدالها.
جميع أسماء المنتجات والعلامات التجارية والأسماء التجارية مملوكة لأصحابها، ولا يعني استخدامها أي انتماء أو تأييد. لا تتحمل شركة سيدمكس إينوفيا أي مسؤولية عن أي تبعات ناتجة عن استخدام المعلومات الواردة في هذا الموقع الإلكتروني.